Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 248

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT02539134
TAK-935 Multiple Rising Dose Study in Healthy Participants
TAK-935 Épilepsie Phase 1 COMPLETED En attente / non publié Takeda United States · Austin — centre non communiqué, Austi… 2015-09 → 2016-04 Ouvrir
NCT02497235
A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S…
TAK-935 Épilepsie Phase 1 COMPLETED En attente / non publié Takeda United States · New Haven — centre non communiqué, Ne… 2015-07 → 2016-01 Ouvrir
NCT07821697
TRCE — Translational Recording and Characterization of Epilepsy Signals…
EEG Record only Épilepsie Phase 1 NOT_YET_RECRUITING En attente / non publié Adraxe Corp. United States · University of Minnisota, Minneapolis,… 2026-10-15 → 2027-12-31 Ouvrir
NCT07823465
AURORA — RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A…
NeuroPace RNS System Épilepsie À vérifier ENROLLING_BY_INVITATION En attente / non publié NeuroPace United States · OM1's Central Site (Virtual Site), Wa… 2026-09-14 → 2027-05 Ouvrir
NCT07110454
DETECT LTFU — Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
Previous receipt of the Minder Sy… Épilepsie À vérifier RECRUITING En attente / non publié Epiminder America, Inc. United States · Atrium Health Neurosciences Institute… 2025-12-23 → 2029-01 Ouvrir
NCT06118255
ORCHID — A Study to Evaluate Safety, Tolerability, and Pharmacokinetics…
fenfluramine Épilepsie Phase 3 COMPLETED En attente / non publié KU Leuven United States, Belgium, Germany, Italy, United Kingdo… 2024-05-21 → 2026-09-01 Ouvrir
NCT06660394
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children an…
LP352 Épilepsie Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Longboard Pharmaceuticals United States, Australia, Belgium, Brazil, Canada, Ch… 2024-09-25 → 2026-12-31 Ouvrir
NCT03166215
Study of TAK-935 as an Adjunctive Therapy in Participants With Developm…
TAK-935 Épilepsie Phase 1/2 COMPLETED En attente / non publié Takeda United States · Bluegrass Epilepsy Research, Lexingto… 2017-08-17 → 2018-09-19 Ouvrir
NCT03999164
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
[18F]DPA-714 Positron Emission To… Épilepsie Phase 1 ACTIVE_NOT_RECRUITING En attente / non publié University of California, Davis United States · University of California, Davis, Sacr… 2020-02-01 → 2026-11-14 Ouvrir
NCT03650452
ELEKTRA — A Phase 2, Multicenter, Randomized, Double-blind, Placebo-con…
TAK-935 Épilepsie Phase 2 COMPLETED En attente / non publié Takeda United States, Australia, Canada, China, Israel, Pola… 2018-08-08 → 2020-07-20 Ouvrir
NCT07088835
SeizEAR Safety Study
SeizEAR Épilepsie Non applicable RECRUITING En attente / non publié Icahn School of Medicine at Mount… United States · Icahn School of Medicine at Mount Sin… 2025-05-08 → 2026-12-31 Ouvrir
NCT05101161
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
Neurofeedback Using Implanted Dee… Épilepsie Non applicable RECRUITING En attente / non publié ETH Zurich Switzerland · ETH Zurich, Zurich, Switzerland 2021-09-23 → 2028-09-23 Ouvrir
NCT04940624
A Study of Soticlestat as an Add-on Therapy in Children and Young Adult…
Soticlestat Épilepsie Phase 3 COMPLETED En attente / non publié Takeda United States, Australia, Brazil, Canada, China, Fran… 2021-10-28 → 2024-04-11 Ouvrir
NCT07803692
HIFU for MRGE — High-Intensity Focused Ultrasonic Ablation of the Centr…
Intervention 1 Épilepsie Non applicable NOT_YET_RECRUITING En attente / non publié Oregon Health and Science Univers… United States · Oregon Health & Science University, P… 2027-02 → 2031-06 Ouvrir
NCT03635073
Endymion 1 — A Study of Soticlestat in Adults and Children With Rare Ep…
Soticlestat Épilepsie Phase 2 TERMINATED En attente / non publié Takeda United States, Australia, Canada, China, Israel, Pola… 2018-07-19 → 2025-07-30 Ouvrir
NCT06422377
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or …
Soticlestat Épilepsie Phase 3 TERMINATED En attente / non publié Takeda Denmark · Epilepsihospitalet Filadelfia, Dianalund, D… 2024-04-25 → 2024-08-14 Ouvrir
NCT05163314
A Study of Soticlestat as an Add-on Therapy in Children and Adults With…
Soticlestat Épilepsie Phase 3 TERMINATED En attente / non publié Takeda United States, Australia, Belgium, Brazil, Canada, Ch… 2022-03-04 → 2025-09-24 Ouvrir
NCT06280092
Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy Du…
AMSCs Épilepsie Phase 1 TERMINATED En attente / non publié Mayo Clinic United States · Mayo Clinic, Jacksonville, United Sta… 2024-12-23 → 2026-09-03 Ouvrir
NCT06581133
Sleep Disruption Pattern - Epilepsy Monitoring Unit
Alarm system Épilepsie Non applicable NOT_YET_RECRUITING En attente / non publié Duke University Non communiqué 2026-10-01 → 2027-12-01 Ouvrir
NCT02694094
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epile…
Impact of Ketogenic Diets on Card… Épilepsie À vérifier ACTIVE_NOT_RECRUITING En attente / non publié Johns Hopkins University United States · Johns Hopkins University, Baltimore, … 2016-03 → 2027-03 Ouvrir
NCT06634901
Health Literacy Project
Health Literacy Project Épilepsie Non applicable NOT_YET_RECRUITING En attente / non publié Duke University Uganda · Mayanja Memorial Hospital, Mbarara, Uganda |… 2026-11-01 → 2027-01-31 Ouvrir
NCT05500703
Brain Regions and Functional Neuronal Network Characteristics of Dexmed…
Dexmedetomidine Injectable Soluti… Épilepsie Phase 4 COMPLETED En attente / non publié China International Neuroscience … China · Xuanwu Hospital, Beijing, China 2024-01-15 → 2024-12-20 Ouvrir
NCT03694275
A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) i…
Soticlestat Épilepsie Phase 2 COMPLETED En attente / non publié Takeda United States · Boston Children's Hospital Translatio… 2018-09-10 → 2020-07-31 Ouvrir
NCT04938427
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and…
Soticlestat Épilepsie Phase 3 COMPLETED En attente / non publié Takeda United States, Australia, Belgium, Canada, China, Fra… 2021-11-08 → 2024-01-25 Ouvrir
NCT05947656
Evaluation of the NaviFUS System in Drug Resistant Epilepsy
NaviFUS System Épilepsie Non applicable RECRUITING En attente / non publié NaviFUS Corporation Australia · The Alfred, Melbourne, Australia 2023-10-02 → 2027-06-01 Ouvrir